Junfang Xu

2.1k total citations · 2 hit papers
19 papers, 1.5k citations indexed

About

Junfang Xu is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Junfang Xu has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Junfang Xu's work include interferon and immune responses (8 papers), Cancer-related molecular mechanisms research (6 papers) and Immune cells in cancer (4 papers). Junfang Xu is often cited by papers focused on interferon and immune responses (8 papers), Cancer-related molecular mechanisms research (6 papers) and Immune cells in cancer (4 papers). Junfang Xu collaborates with scholars based in China, Croatia and United States. Junfang Xu's co-authors include Xuetao Cao, Pin Wang, Qiuyan Liu, Cong Wu, Yiquan Xue, Zhengping Jiang, Yanmei Han, Lin Li, Sheng Xu and Yujia Wang and has published in prestigious journals such as Science, Immunity and Molecular Cell.

In The Last Decade

Junfang Xu

18 papers receiving 1.5k citations

Hit Papers

The STAT3-Binding Long Noncoding RNA lnc-DC Controls Huma... 2014 2026 2018 2022 2014 2025 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junfang Xu China 10 1.1k 1.0k 458 178 106 19 1.5k
Jane McBride United States 12 680 0.6× 657 0.6× 264 0.6× 106 0.6× 61 0.6× 23 1.2k
Jie Dong China 17 304 0.3× 767 0.7× 158 0.3× 132 0.7× 192 1.8× 53 1.1k
Patricia Landry Canada 15 497 0.5× 624 0.6× 105 0.2× 99 0.6× 93 0.9× 24 1.2k
Ulf Gehrmann Sweden 16 402 0.4× 1.0k 1.0× 833 1.8× 184 1.0× 184 1.7× 33 1.7k
Bo–Sheng Li China 18 1.0k 1.0× 1.1k 1.1× 299 0.7× 121 0.7× 36 0.3× 30 1.7k
Bin Xiao China 17 940 0.9× 924 0.9× 218 0.5× 108 0.6× 41 0.4× 19 1.4k
Lun Liu China 10 348 0.3× 424 0.4× 317 0.7× 93 0.5× 50 0.5× 16 755
Osamu Hitotsumatsu United States 5 640 0.6× 580 0.6× 1.1k 2.5× 157 0.9× 47 0.4× 5 1.5k
Satinder Dahiya United States 11 337 0.3× 576 0.6× 725 1.6× 114 0.6× 123 1.2× 18 1.4k
Rizwan Ahmad Ireland 2 540 0.5× 482 0.5× 860 1.9× 113 0.6× 31 0.3× 5 1.2k

Countries citing papers authored by Junfang Xu

Since Specialization
Citations

This map shows the geographic impact of Junfang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfang Xu more than expected).

Fields of papers citing papers by Junfang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfang Xu. The network helps show where Junfang Xu may publish in the future.

Co-authorship network of co-authors of Junfang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Junfang Xu. A scholar is included among the top collaborators of Junfang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfang Xu. Junfang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Qiang, Qinghua Yao, Wenfang Li, et al.. (2025). Nonenzymatic lysine d-lactylation induced by glyoxalase II substrate SLG dampens inflammatory immune responses. Cell Research. 35(2). 97–116. 24 indexed citations breakdown →
2.
Su, Hang, Changyong Hu, Jianxia Chen, et al.. (2025). Development of antibody drug conjugates targeting epithelial membrane protein 2-highly expressed lung cancer. Cell Death and Disease. 16(1). 771–771.
3.
Ma, Mingtong, Mengmeng Zhao, Yajuan Cao, et al.. (2025). Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity. Cell Reports. 44(5). 115572–115572. 1 indexed citations
4.
Qin, Lianhua, Junfang Xu, Jianxia Chen, et al.. (2024). Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growth. eLife. 13. 3 indexed citations
5.
Hao, Bingjie, Shumeng Lin, Haipeng Liu, et al.. (2024). Baicalein tethers CD274/PD-L1 for autophagic degradation to boost antitumor immunity. Autophagy. 21(5). 917–933. 7 indexed citations
6.
Chen, Jianxia, Fen Tang, Haohao Li, et al.. (2023). Mycobacterium tuberculosis suppresses APLP2 expression to enhance its survival in macrophage. International Immunopharmacology. 124(Pt B). 111058–111058. 3 indexed citations
7.
Ma, Mingtong, Fei Wang, Junfang Xu, et al.. (2023). TAK1 is an essential kinase for STING trafficking. Molecular Cell. 83(21). 3885–3903.e5. 32 indexed citations
8.
Chen, Li, Mengmeng Zhao, Junfang Xu, et al.. (2023). A non‐canonical role of endothelin converting enzyme 1 (ECE1) in promoting lung cancer development via directly targeting protein kinase B (AKT). The Journal of Gene Medicine. 26(1). e3612–e3612. 4 indexed citations
9.
Gao, Jiani, Xiangyang Wu, Hang Su, et al.. (2022). CDK inhibitor Palbociclib targets STING to alleviate autoinflammation. EMBO Reports. 23(6). e53932–e53932. 46 indexed citations
10.
Wang, Fei, Ming Tong, Junfang Xu, & Haipeng Liu. (2022). Identification of phosphorylation site on PARP1 mediating its cytosolic translocation in virus-infected HeLa cells. STAR Protocols. 3(4). 101808–101808. 1 indexed citations
11.
Wang, Qiang, Tengjiao Wang, Junfang Xu, et al.. (2021). Pattern Recognition Receptors (PRRs) in Macrophages Possess Prognosis and Immunotherapy Potential for Melanoma. Frontiers in Immunology. 12. 765615–765615. 9 indexed citations
12.
Xu, Junfang, Pin Wang, Zhiqing Li, et al.. (2021). IRF3-binding lncRNA-ISIR strengthens interferon production in viral infection and autoinflammation. Cell Reports. 37(5). 109926–109926. 26 indexed citations
13.
Wang, Yujia, Pin Wang, Yunkai Zhang, et al.. (2020). Decreased Expression of the Host Long-Noncoding RNA-GM Facilitates Viral Escape by Inhibiting the Kinase activity TBK1 via S-glutathionylation. Immunity. 53(6). 1168–1181.e7. 57 indexed citations
14.
Wang, Yujia, Junfang Xu, Pin Wang, et al.. (2019). LncRNA-GM Facilitates Antiviral Innate Immunity by Binding GSTM1 to Reduce S-glutathionylation and Enhance Activity of TBK1. SSRN Electronic Journal. 1 indexed citations
15.
Xu, Junfang & Xuetao Cao. (2018). Long noncoding RNAs in the metabolic control of inflammation and immune disorders. Cellular and Molecular Immunology. 16(1). 1–5. 32 indexed citations
16.
Xu, Junfang, et al.. (2017). Air–water dual-source heat pump system with new composite evaporator. Applied Thermal Engineering. 141. 483–493. 30 indexed citations
17.
Wang, Pin, Junfang Xu, Yujia Wang, & Xuetao Cao. (2017). An interferon-independent lncRNA promotes viral replication by modulating cellular metabolism. Science. 358(6366). 1051–1055. 240 indexed citations
18.
Wang, Pin, Yiquan Xue, Yanmei Han, et al.. (2014). The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation. Science. 344(6181). 310–313. 884 indexed citations breakdown →
19.
Wu, Cong, Yiquan Xue, Pin Wang, et al.. (2014). IFN-γ Primes Macrophage Activation by Increasing Phosphatase and Tensin Homolog via Downregulation of miR-3473b. The Journal of Immunology. 193(6). 3036–3044. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026